Seeing Is Believing
Currently out of the existing stock ratings of Vikram Purohit, 55 are a BUY (44.35%), 66 are a HOLD (53.23%), 3 are a SELL (2.42%).
Analyst Vikram Purohit works at MORGAN STANLEY with a stock forecast success ratio of 40.49% fulfilled within 94.5 days on average.
Vikram Purohit’s has documented 289 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SAGE, Sage Therapeutic at 28-Feb-2024.
Analyst best performing recommendations are on ARQT (ARCUTIS BIOTHERAPEUTICS ).
The best stock recommendation documented was for ARQT (ARCUTIS BIOTHERAPEUTICS ) at 12/21/2023. The price target of $11 was fulfilled within 71 days with a profit of $8.4 (323.08%) receiving and performance score of 45.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
190
$110.83 (139.99%)
180
2 days ago
6/23 (26.09%)
$113.28 (147.65%)
108
Buy
108
$28.83 (36.42%)
112
1 months 1 days ago
8/13 (61.54%)
$24 (28.57%)
148
Buy
125
$45.83 (57.89%)
110
1 months 7 days ago
5/10 (50%)
$42.89 (52.23%)
82
Buy
108
$28.83 (36.42%)
108
1 months 8 days ago
7/15 (46.67%)
$26.86 (33.10%)
49
Buy
111
$31.83 (40.20%)
66
1 months 22 days ago
1/2 (50%)
$16.19 (17.08%)
157
Which stock is Vikram Purohit is most bullish on?
Which stock is Vikram Purohit is most reserved on?
What Year was the first public recommendation made by Vikram Purohit?